U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07543887) titled 'Selpercatinib and Body Composition' on April 05.
Brief Summary: investigation of body composition
Study Start Date: April 12, 2024
Study Type: OBSERVATIONAL
Condition:
Thyroid Cancer
Intervention:
OTHER: observation in patient under treatment
observation in patient under treatment
DRUG: Selpercatinib
observational study of patients under selpercatinib
Recruitment Status: COMPLETED
Sponsor: University of Pisa
Information provided by (Responsible Party): Alessio Basolo, University of Pisa
Disclaimer: Curated by HT Syndication....